Please use this identifier to cite or link to this item: https://apo.ansto.gov.au/dspace/handle/10238/9015
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMédoc, M-
dc.contributor.authorDhilly, M-
dc.contributor.authorMatesic, L-
dc.contributor.authorToutain, J-
dc.contributor.authorKrause-Heuer, AM-
dc.contributor.authorDelamare, J-
dc.contributor.authorFraser, BH-
dc.contributor.authorTouzani, O-
dc.contributor.authorBarré, L-
dc.contributor.authorGreguric, I-
dc.contributor.authorSobrio, F-
dc.date.accessioned2018-09-18T05:57:42Z-
dc.date.available2018-09-18T05:57:42Z-
dc.date.issued2016-02-01-
dc.identifier.citationMédoc, M., Dhilly, M., Matesic, L., Toutain, J., Krause-Heuer, A. M., Delamare, J., Fraser, B. H., Touzani, O., Barré, L., Greguric, I., & Sobrio, F. (2016). In vivo evaluation of radiofluorinated caspase-3/7 inhibitors as radiotracers for apoptosis imaging and comparison with [18F]ML-10 in a stroke model in the rat. Molecular Imaging and Biology, 18(1), 117-126. doi:10.1007/s11307-015-0865-1en_AU
dc.identifier.govdoc8821-
dc.identifier.issn1860-2002-
dc.identifier.urihttps://doi.org/10.1007/s11307-015-0865-1en_AU
dc.identifier.urihttp://apo.ansto.gov.au/dspace/handle/10238/9015-
dc.description.abstractThe first biological evaluation of two potent fluorine-18 radiolabelled inhibitors of caspase-3/7 was achieved in a cerebral stroke rat model to visualize apoptosis © Springer Natureen_AU
dc.language.isoenen_AU
dc.publisherSpringer Natureen_AU
dc.subjectFluorine 18en_AU
dc.subjectIschemiaen_AU
dc.subjectIn vivoen_AU
dc.subjectApoptosisen_AU
dc.subjectCysteineen_AU
dc.subjectEnzyme inhibitorsen_AU
dc.subjectTracer techniquesen_AU
dc.titleIn vivo evaluation of radiofluorinated caspase-3/7 inhibitors as radiotracers for apoptosis imaging and comparison with [18F]ML-10 in a stroke model in the raten_AU
dc.typeJournal Articleen_AU
Appears in Collections:Journal Articles

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.